Eventide Healthcare & Life Sciences Fd Cl N (ETNHX) Fund Overview
Educational signal · not a buy or sell recommendation · How to read this
Beta 1.27: the stock has moved about 27% more than the S&P 500.
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerEventide Healthcare & Life Sciences Fd Cl N (ETNHX) trades at $52.20. Eventide Healthcare & Life Sciences Fd Cl N is a non-diversified, open-end management investment company. Sector: Financials.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for ETNHX: ETNHX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
Eventide Healthcare & Life Sciences Fd Cl N (ETNHX) Financial Services Profile
Eventide Healthcare & Life Sciences Fd Cl N is an asset management firm specializing in the healthcare and life sciences sectors. The fund invests in companies of any market capitalization, both domestically and internationally, through equity and equity-related securities, including ADRs, to achieve long-term capital appreciation.
What Is the Investment Thesis for ETNHX?
Eventide Healthcare & Life Sciences Fd Cl N presents a focused investment opportunity within the growing healthcare and life sciences sectors. With a beta of 1.27, the fund exhibits slightly higher volatility compared to the market. The fund's strategy of investing at least 80% of its assets in healthcare and life sciences companies positions it to benefit from the sector's long-term growth trends, driven by factors such as an aging global population and advancements in medical technology. The fund's ability to invest in companies of any market capitalization and across international markets provides diversification and access to a wider range of opportunities. However, the fund's non-diversified nature increases its susceptibility to sector-specific risks. The absence of a dividend yield may deter some income-seeking investors.
Based on FMP financials and quantitative analysis
ETNHX Key Highlights
The fund invests at least 80% of its net assets in equity and equity-related securities of companies in the healthcare and life sciences sectors.
- Eventide Healthcare & Life Sciences Fd Cl N can invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts (ADRs).
- The fund may invest in securities of companies of any market capitalization.
- The fund has a beta of 1.27, indicating slightly higher volatility compared to the market.
- The fund's market capitalization is $1.25 billion.
Who Are ETNHX's Competitors?
ETNHX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AEMGX Acadian Emerging Markets Investor | $35.98 | +0.93% | $1.95B | — |
| AEMZX Acadian Emerging Markets Portfolio Class I | $35.98 | +0.90% | $1.89B | — |
| AOOIX American Century One Choice 2045 Portfolio - I Class | $18.79 | +0.54% | $1.24B | — |
| AROIX American Century One Choice 2045 Portfolio Investor Class | $18.75 | +0.59% | $1.23B | — |
| ARWIX American Century One Choice 2025 Portfolio Investor Class | $13.22 | -0.75% | $1.30B | — |
| BLK BlackRock, Inc. | $1059.63 | -0.44% | $164B | 51 5-pillar |
| BX Blackstone Inc. | $111.74 | -0.45% | $135B | 68 5-pillar |
| APOS Apollo Global Management, Inc. | $25.59 | -0.23% | $74.8B | 56 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are ETNHX's Key Strengths?
Specialized focus on high-growth healthcare and life sciences sectors.
- Global investment mandate allows for diversification and access to international opportunities.
- Flexibility to invest in companies of any market capitalization.
- Experienced investment team with deep industry knowledge.
What Are ETNHX's Weaknesses?
Non-diversified nature increases sector-specific risk.
- Reliance on the performance of the healthcare and life sciences sectors.
- Absence of dividend yield may deter income-seeking investors.
- Higher beta indicates greater volatility compared to the overall market.
What Are the Key Risks for ETNHX?
Regulatory changes and healthcare policy reforms could negatively impact the profitability of portfolio companies.
- Economic downturns and market volatility could lead to declines in asset values.
- Competition from other asset management firms could reduce market share.
- Sector-specific risks associated with the healthcare and life sciences industries.
What Are ETNHX's Competitive Advantages?
- Specialized Expertise: Deep understanding of the healthcare and life sciences sectors.
- Global Investment Reach: Ability to invest in companies worldwide through ADRs and direct investments.
- Flexible Investment Mandate: Can invest in companies of any market capitalization.
What Does ETNHX Do?
Eventide Healthcare & Life Sciences Fd Cl N is a non-diversified, open-end management investment company that directs its investments towards the healthcare and life sciences sectors. The fund's strategy involves investing at least 80% of its net assets, along with any borrowings for investment purposes, in the equity and equity-related securities of companies operating within these sectors. This includes common stock, options, preferred stock, and convertible debt. The fund has the flexibility to invest in companies of any market capitalization, allowing it to tap into both established and emerging players in the healthcare and life sciences industries. Eventide Healthcare & Life Sciences Fd Cl N can invest without limitation in securities of companies domiciled outside the United States either directly or through American Depositary Receipts (ADRs). This global approach enables the fund to access a broader range of investment opportunities and potentially enhance its returns by capitalizing on international healthcare and life sciences trends. The fund aims to provide investors with long-term capital appreciation by focusing on companies that demonstrate strong growth potential and innovation within these critical sectors. The fund's investment decisions are guided by in-depth research and analysis of the healthcare and life sciences landscape, seeking to identify companies with sustainable competitive advantages and the potential to generate significant value for shareholders.
What Products and Services Does ETNHX Offer?
- Invests primarily in equity and equity-related securities.
- Focuses on companies within the healthcare and life sciences sectors.
- Invests at least 80% of net assets in healthcare and life sciences companies.
- May invest in companies of any market capitalization.
- Can invest in securities of companies domiciled outside the United States.
- Utilizes American Depositary Receipts (ADRs) for international investments.
How Does ETNHX Make Money?
- Generates revenue through management fees charged on assets under management (AUM).
- Aims to achieve long-term capital appreciation for its investors.
- Employs a research-driven investment approach to identify promising healthcare and life sciences companies.
What Industry Does ETNHX Operate In?
Eventide Healthcare & Life Sciences Fd Cl N operates within the asset management industry, focusing specifically on the healthcare and life sciences sectors. These sectors are experiencing robust growth, driven by factors such as an aging global population, increasing healthcare spending, and advancements in biotechnology and pharmaceuticals. The competitive landscape includes other asset management firms offering healthcare-focused funds, each with varying investment strategies and risk profiles. The fund's ability to invest globally and across market capitalizations differentiates it from some competitors, providing access to a broader range of investment opportunities.
Who Are ETNHX's Key Customers?
- Individual investors seeking exposure to the healthcare and life sciences sectors.
- Institutional investors looking for specialized investment strategies.
- Retirement plans and endowments seeking long-term growth opportunities.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● Price is current
- ● No filing on record
- ● No analyst coverage
- ● This is a fund, not an operating company
MoonshotScore History
Recorded daily since 2026-08-23 · 41 snapshots
| 2026-08-23 | 56 |
| 2026-08-31 | 56 |
| 2026-09-08 | 56 |
| 2026-09-16 | 56 |
| 2026-09-24 | 56 |
| 2026-10-04 | 56 |
What changed?
The score has stayed at 56.
Over the same 30 days the stock moved -10.4%.
ETNHX Financials
Bull Case vs Bear Case
Bull Case
- Specialized focus on high-growth healthcare and life sciences sectors.
- Global investment mandate allows for diversification and access to international opportunities.
- Flexibility to invest in companies of any market capitalization.
- Experienced investment team with deep industry knowledge.
Bear Case
- Non-diversified nature increases sector-specific risk.
- Reliance on the performance of the healthcare and life sciences sectors.
- Absence of dividend yield may deter income-seeking investors.
- Higher beta indicates greater volatility compared to the overall market.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
ETNHX Latest News
No recent news available for ETNHX.
ETNHX Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for ETNHX.
Price Targets
Wall Street price target analysis for ETNHX.
ETNHX MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for ETNHX; grades run from A+ (80-100) to F (below 30).
What Investors Ask About Eventide Healthcare & Life Sciences Fd Cl N (ETNHX) — Financials
What does Eventide Healthcare & Life Sciences Fd Cl N do?
Eventide Healthcare & Life Sciences Fd Cl N is an investment fund that focuses on investing in companies within the healthcare and life sciences sectors.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.